Chelsea and Westminster Hospital pioneers autonomous artificial intelligence (AI) pathway for skin cancer to discharge harmless cases
Posted:
Chelsea and Westminster Hospital NHS Foundation Trust is utilising digital innovation and world-first autonomous technology to identify harmless (benign) skin lesions without review from the dermatology team, to be able to discharge patients on the same day as they receive their results.
This advanced AI skin cancer pathway helps clinicians and dermatologists effectively triage patients, enabling earlier detection.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
From detecting TB, cancer, and heart attacks to diagnosing patients with strokes and diabetes, Artificial Intelligence (AI) is redefining the healthcare system across the world. Currently, more than 90% of hospitals and healthcare systems have implemented an AI or automation strategy,…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us